The FORT test: Reply to Dr Harma and colleagues

Atherosclerosis

Volumn 187, Issue 2, 2006, Pages 443-444

  Abramson, Jerome L ^a   Jones, Dean P ^b   Ashfaq, Salman ^c   Rhodes, Steven D ^b   Harrison, David G ^b   Vaccarino, Viola ^b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; FREE RADICAL; HYDROGEN PEROXIDE; OXYGEN RADICAL;

CALIBRATION; FENTON REACTION; HUMAN; LETTER; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 33745508758     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.02.029     Document Type: Letter

References (6)

1. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38 (2005) 1103-1111
2. Atanasiu R.L., Stea D., Mateescu M.A., et al. Direct evidence of caeruloplasmin antioxidant properties. Mol Cell Biochem 189 (1998) 127-135
3. Levy M.A., Tsai Y.H., Reaume A., and Bray T.M. Cellular response of antioxidant metalloproteins in Cu/Zn SOD transgenic mice exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 281 (2001) L172-L182
4. Mukhopadhyay C.K., Ehrenwald E., and Fox P.L. Ceruloplasmin enhances smooth muscle cell- and endothelial cell-mediated low density lipoprotein oxidation by a superoxide-dependent mechanism. J Biol Chem 271 (1996) 14773-14778
5. Shukla N., Maher J., Masters J., Angelini G.D., and Jeremy J.Y. Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor?. Atherosclerosis (2006)
6. Awadallah S.M., Hamad M., Jbarah I., Salem N.M., and Mubarak M.S. Autoantibodies against oxidized LDL correlate with serum concentrations of ceruloplasmin in patients with cardiovascular disease. Clin Chim Acta (2005)